Corcept Therapeutics (CORT) Non-cash Items (2012 - 2017)

Corcept Therapeutics has disclosed Non-cash Items across 6 years of filings, most recently posting $263.1 million for Q4 2017.

• Non-cash Items for Q4 2017 came in at $263.1 million, up 310.36% year-over-year; the trailing twelve-month figure through Dec 2017 was $263.1 million (up 310.36% YoY), and the FY2017 annual result was $263.1 million, up 310.36% from the prior year.
• Non-cash Items came in at $263.1 million for Q4 2017 at Corcept Therapeutics, up from $64.1 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $263.1 million in Q4 2017 to a low of $10.5 million in Q4 2014.
• The 5-year median for Non-cash Items is $14.3 million (2013), against an average of $72.5 million.
• Across the five-year window, Non-cash Items surged 1905.2% in 2013 and fell 26.43% in 2014, its largest moves.
• Corcept Therapeutics' Non-cash Items stood at $14.3 million in 2013, then decreased by 26.43% to $10.5 million in 2014, then advanced by 1.43% to $10.6 million in 2015, then soared by 502.71% to $64.1 million in 2016, then soared by 310.36% to $263.1 million in 2017.
• The last three Non-cash Items figures came in at $263.1 million (Q4 2017), $64.1 million (Q4 2016), and $10.6 million (Q4 2015), per Business Quant data.